ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Direct · Growth
NAV
₹46.1100
as of 30 Sept 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +9.79%
- 3Y
- +21.28%
- 5Y
- +15.65%
- Since Inception
- +20.45%
SIP returns (XIRR)
- 1Y
- +10.46%
- 3Y
- +13.98%
- 5Y
- +19.21%
- Since Inception
- +21.10%
Performance Comparison
Sectoral allocation
as of 30 Jun 2026- Pharmaceuticals & Biotechnology75.78%
- Healthcare Services11.50%
- Retailing5.35%
- Insurance1.33%
- Chemicals & Petrochemicals1.33%
- Healthcare Equipment & Supplies0.77%
Each sector links to the mutual funds most exposed to it.
Thinking about ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
portfolio shared with ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option
- 1Sun Pharmaceutical Industries Ltd.12.69%
- 2Dr. Reddy'S Laboratories Ltd.8.45%
- 3Cipla Ltd.6.56%
- 4Divi'S Laboratories Ltd.6.03%
- 5Mankind Pharma Ltd.5.47%
- 6Alkem Laboratories Ltd.5.11%
- 7Biocon Ltd.4.97%
- 8Cohance Lifesciences Ltd.3.92%
- 9Medplus Health Services Ltd3.80%
- 10Syngene International Ltd.3.26%
What this fund does
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by ICICI Prudential Mutual Fund. The fund has been operational for over 8 years.